Case Report: Sequential Chemotherapy and Immunotherapy Produce Sustained Response in Osteosarcoma With High Tumor Mutational Burden
BackgroundImmunotherapy has provided an effective method for the treatment of many cancers. However, its efficacy in osteosarcoma is not satisfactory so far.Case PresentationHere, we presented a case of osteosarcoma treated with sequential chemotherapy and immunotherapy and showed promising therapeu...
Main Authors: | Shuier Zheng, Fenglin Wang, Jin Huang, Yan Zhou, Quanjun Yang, Guowei Qian, Chenliang Zhou, Daliu Min, Lele Song, Zan Shen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-06-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2021.625226/full |
Similar Items
-
The Clinical Implications of Tumor Mutational Burden in Osteosarcoma
by: Lu Xie, et al.
Published: (2021-04-01) -
Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine
by: Cecilia Gola, et al.
Published: (2021-05-01) -
Influence of low tumor content on tumor mutational burden estimation by whole‐exome sequencing and targeted panel sequencing
by: Wenxin Zhang, et al.
Published: (2021-05-01) -
Pre-Treatment Mutational and Transcriptomic Landscape of Responding Metastatic Melanoma Patients to Anti-PD1 Immunotherapy
by: Carol M. Amato, et al.
Published: (2020-07-01) -
Data Interoperability of Whole Exome Sequencing (WES) Based Mutational Burden Estimates from Different Laboratories
by: Ping Qiu, et al.
Published: (2016-04-01)